[Athrombocytosis during cefotaxim-azlocillin combination therapy].
D001390:Azlocillin / Q000009:adverse effects*; D002439:Cefotaxime / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008875:Middle Aged; D013921:Thrombocytopenia / Q000139:chemically induced*
D001390:Azlocillin; D002439:Cefotaxime
Athrombozytose unter Cefotaxim-Azlocillin-Kombinationstherapie.